Document is current
Any future updates will be listed below
-
Authors
Bell, Alexander J.
Masotti, Maria
Ram, Sundaresh
Pappas, Gregory
Miller, Robert F.
Kazerooni, Ella A.
Hatt, Charles R.
Han, MeiLan K.
Richmond, Bradley W.
Falvo, Michael J.
Galban, Craig J.
Osterholzer, John J.
-
Funding
Funding for this research was provided by:
U.S. Department of Defense (GW16015, GW16015, GW16015, GW16015, GW16015)
U.S. Department of Veterans Affairs (Merit Review Award (JJO), Merit Review Award (JJO), Merit Review Award (JJO), Merit Review Award (JJO), Merit Review Award (JJO))
- License Information
-
More Information
Article History
Received: 6 February 2025
Accepted: 6 May 2025
First Online: 21 May 2025
Declarations
:
: The study was conducted in accordance with approvals obtained following IRB review at the following institutions: VA Ann Arbor Health System (1754681) the University of Michigan (HUM00246250) and the Vanderbilt Medical Center.
: Not applicable.
: Craig Galban reports a relationship with Imbio Inc that includes equity or stocks. Imbio Inc originally held the license of the parametric response mapping technology used in our analysis. Charles Hatt reports a relationship with 4D Medicine Ltd that includes employment. 4D Medicine Ltd now holds the license for the parametric response mapping technology used in our analysis.
